Verona Pharma, Inc., A Subsidiary Of Merck & Co., Inc. (rahway, New Jersey Usa
Clinical trials sponsored by Verona Pharma, Inc., A Subsidiary Of Merck & Co., Inc. (rahway, New Jersey Usa, explained in plain language.
-
New COPD inhaler shows promise in quick lung function boost
Disease control CompletedThis study tested three doses of an inhaled medicine called glycopyrrolate in 46 adults with COPD. Each person received the medicine or a placebo for one week at a time. The goal was to see if the medicine improved lung function and was safe. The trial is complete, and results wi…
Phase: PHASE2 • Sponsor: Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA • Aim: Disease control
Last updated May 17, 2026 00:48 UTC
-
New COPD combo inhaler shows promise in early trial
Disease control CompletedThis study tested a new inhaled drug combination (ensifentrine plus glycopyrrolate) in 33 adults with COPD. The goal was to see how the drug moves through the body, how well it opens airways, and if it is safe. Participants received single doses of the combination and each drug a…
Phase: PHASE2 • Sponsor: Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA • Aim: Disease control
Last updated May 11, 2026 20:40 UTC